10-year trends in benzodiazepine, opioid, and concurrent use in hip and knee arthroplasty: a nationwide cohort study from the Netherlands

Authors

  • Manuela Yepes-Calderón Department of Orthopaedics, Leiden University Medical Center, Leiden; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands
  • Rob G H H Nelissen Department of Orthopaedics, Leiden University Medical Center, Leiden; Dutch Arthroplasty Register (LROI), ’s-Hertogenbosch, the Netherlands https://orcid.org/0000-0003-1228-4162
  • Marcel L Bouvy Utrecht Institute for Pharmaceutical Sciences (UIPS), Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, the Netherlands
  • Frits R Rosendaal Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands
  • Liza N van Steenbergen Dutch Arthroplasty Register (LROI), ’s-Hertogenbosch, the Netherlands https://orcid.org/0000-0002-8141-842X
  • Albert Dahan Department of Anesthesiology, Leiden University Medical Center, Leiden, the Netherlands
  • Maaike G J Gademan Department of Orthopaedics, Leiden University Medical Center, Leiden; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands https://orcid.org/0000-0002-6106-3385

DOI:

https://doi.org/10.2340/17453674.2025.44755

Keywords:

Arthroplasty, Benzodiazepines, Concurrent use, Opioids, Pharmacoepidemiology

Abstract

Background and purpose: Concurrent benzodiazepine–opioid use is discouraged. We aimed to examine trajectories of benzodiazepine, opioid, and concurrent use following hip and knee arthroplasties for osteoarthritis (HA-OA, KA) and hip arthroplasty for fracture (HA-fracture).
Methods: In this nationwide cohort study, the Dutch Arthroplasty Register (LROI) was linked to the Dutch Foundation for Pharmaceutical Statistics (SFK). We evaluated the proportion of patients with ≥ 1 medication dispensation in the year pre- and post-procedure and the prescribing physicians. Concurrent use was defined as ≥ 7 days overlap of benzodiazepine and opioid exposure.
Results: We included 109,238 HA-OA, 17,464 HA fracture, and 113,306 KA. Between 2013 and 2021, the risk difference of postoperative benzodiazepine use was –7.2% (95% confidence interval [CI] –8.1 to –6.2%), while postoperative opioid use increased by 29.7% (CI 28.5–30.8%). Among HA-OA, from 2013 (4,391 arthroplasties) to 2021 (12,905 arthroplasties), the percentage of preoperative benzodiazepine users went from 18% to 13%, and postoperative from 23% to 14%. In contrast, preoperative opioid use changed from 25% to 33% and postoperative from 36% to 69%, In 2021, 6% of HA-OA, 11% of HA fracture, and 9% of KA received a concurrent dispensation in the first post-procedure year, predominantly in the first quarter. Orthopedic surgeons prescribed 29% (~18,732 prescriptions) of initial concurrent dispensations; subsequent prescriptions were mainly from general practitioners.
Conclusion: From 2013–2022 in the Netherlands, benzodiazepine use decreased while opioid use increased among arthroplasty patients. Concurrent use remained frequent, despite safety recommendations against co-prescribing.

Downloads

Download data is not yet available.

References

Thaler M, Khosravi I, Hirschmann M T, Kort N P, Zagra L, Epinette J A, et al. Disruption of joint arthroplasty services in Europe during the COVID-19 pandemic: an online survey within the European Hip Society (EHS) and the European Knee Associates (EKA). Knee Surg Sports Traumatol Arthrosc 2020; 28(6): 1712-19. doi: 10.1007/s00167-020-06033-1. DOI: https://doi.org/10.1007/s00167-020-06033-1

Worlicek M, Koch M, Daniel P, Freigang V, Angele P, Alt V, et al. A retrospective analysis of trends in primary knee arthroplasty in Germany from 2008 to 2018. Sci Rep 2021; 11(1): 5225. doi: 10.1038/s41598-021-84710-y. DOI: https://doi.org/10.1038/s41598-021-84710-y

Van Brug H E, Nelissen R G H H, Lijfering W M, Van Steenbergen L N, Rosendaal F R, Van Dorp E L A, et al. Opioid prescribing patterns after arthroplasty of the knee and hip: a Dutch nationwide cohort study from 2013 to 2018. Acta Orthop 2022; 93: 667-81. doi: 10.2340/17453674.2022.3993.

Lembke A, Papac J, Humphreys K. Our other prescription drug problem. N Engl J Med 2018; 378(8): 693-5. doi: 10.1056/NEJMp1715050. DOI: https://doi.org/10.1056/NEJMp1715050

Dong J Y, Ju J H, Yang Y M. Analysis of the prescription trends of potentially inappropriate medications in Korean older outpatients by sex: a retrospective study using data from the health insurance review and assessment service. Medicine (Baltimore) 2023; 102(34): e34818. doi: 10.1097/MD.0000000000034818. DOI: https://doi.org/10.1097/MD.0000000000034818

Diaz-Gutierrez M J, Martinez-Cengotitabengoa M, Saez de Adana E, Cano A I, Martinez-Cengotitabengoa M T, Besga A, et al. Relationship between the use of benzodiazepines and falls in older adults: a systematic review. Maturitas 2017; 101: 17-22. doi: 10.1016/j.maturitas.2017.04.002. DOI: https://doi.org/10.1016/j.maturitas.2017.04.002

Hernandez N M, Cunningham D J, Hinton Z W, Wu C J, Seyler T M. Are patients taking benzodiazepines at increased risk for complications following primary total knee arthroplasty? J Arthroplasty 2021; 36(5): 1611-16. doi: 10.1016/j.arth.2020.12.004. DOI: https://doi.org/10.1016/j.arth.2020.12.004

Beziz D, Colas S, Collin C, Dray-Spira R, Zureik M. Association between exposure to benzodiazepines and related drugs and survivorship of total hip replacement in arthritis: a population-based cohort study of 246,940 patients. PLoS One 2016; 11(5): e0155783. doi: 10.1371/journal.pone.0155783. DOI: https://doi.org/10.1371/journal.pone.0155783

Kang Y J, Lee M T, Kim M S, You S H, Lee J E, Eom J H, et al. Risk of fractures in older adults with chronic non-cancer pain receiving concurrent benzodiazepines and opioids: a nested case-control study. Drugs Aging 2021; 38(8): 687-95. doi: 10.1007/s40266-021-00872-4. DOI: https://doi.org/10.1007/s40266-021-00872-4

U.S. Food and Drug Administration (FDA). FDA Drug Safety Communication: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning. Available from: https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-warns-about-serious-risks-and-death-when-combining-opioid-pain-or (accessed May 5, 2024).

Landelijke Registratie Orthopedische Interventies (LROI). LROI Report 2024. Available from: https://www.lroi.nl/jaarrapportage/data-quality/completeness/#Overall-completeness-per-procedure (accessed Oct 31, 2024).

Stichting Farmaceutische Kengetallen (SFK). Data en feiten. Stichting Farmaceutische Kengetallen (SFK). Available from: https://www.sfk.nl/publicaties/data-en-feiten

van Brug H E, Nelissen R, Rosendaal F R, van Dorp E L A, Bouvy M L, Dahan A, et al. What changes have occurred in opioid prescriptions and the prescribers of opioids before TKA and THA? A large national registry study. Clin Orthop Relat Res 2023; 481(9): 1716-28. doi: 10.1097/CORR.0000000000002653. DOI: https://doi.org/10.1097/CORR.0000000000002653

Van Brug H E, Nelissen R, Lijfering W M, Van Steenbergen L N, Rosendaal F R, Van Dorp E L A, et al. Opioid prescribing patterns after arthroplasty of the knee and hip: a Dutch nationwide cohort study from 2013 to 2018. Acta Orthop 2022; 93: 667-81. doi: 10.2340/17453674.2022.3993. DOI: https://doi.org/10.2340/17453674.2022.3993

van Brug H E, Nelissen R, Rosendaal F R, van Steenbergen L N, van Dorp E L A, Bouvy M L, et al. Out-of-hospital opioid prescriptions after knee and hip arthroplasty: prescribers and the first prescribed opioid. Br J Anaesth 2023; 130(4): 459-67. doi: 10.1016/j.bja.2022.12.024. DOI: https://doi.org/10.1016/j.bja.2022.12.024

van Brug H E, Rosendaal F R, van Steenbergen L N, Nelissen R, Gademan M G J. Data linkage of two national databases: lessons learned from linking the Dutch Arthroplasty Register with the Dutch Foundation for Pharmaceutical Statistics. PLoS One 2023; 18(3): e0282519. doi: 10.1371/journal.pone.0282519. DOI: https://doi.org/10.1371/journal.pone.0282519

Centraal Bureau voor de Statistiek (CBS). New socioeconomic status scores for districts and neighbourhoods; 2024. Availabel from: https://www.cbs.nl/en-gb/our-services/customised-services-microdata/microdata-conducting-your-own-research/microdatabijeenkomsten/bijeenkomsten/new-socioeconomic-status-scores-for-districts-and-neighbourhoods

Hopkins R E, Bharat C, Buizen L, Close J, Ivers R, Draper B, et al. Age-related risk of serious fall events and opioid analgesic use. JAMA Intern Med 2024; 184(4): 394-401. doi: 10.1001/jamainternmed.2023.8154. DOI: https://doi.org/10.1001/jamainternmed.2023.8154

Shin W Y, Go T H, Kim J H. Trends in commonly used and potentially inappropriate medications in older Korean patients with polypharmacy. BMC Geriatr 2024; 24(1): 542. doi: 10.1186/s12877-024-05141-8. DOI: https://doi.org/10.1186/s12877-024-05141-8

Petein C, Spinewine A, Henrard S. Trends in benzodiazepine receptor agonists use and associated factors in the Belgian general older population: analysis of the Belgian health interview survey data. Ther Adv Psychopharmacol. 2021; 11: 20451253211011874. doi: 10.1177/20451253211011874. DOI: https://doi.org/10.1177/20451253211011874

Ma T T, Wang Z, Qin X, Ju C, Lau W C Y, Man K K C, et al. Global trends in the consumption of benzodiazepines and Z-drugs in 67 countries and regions from 2008 to 2018: a sales data analysis. Sleep 2023; 46(10): zsad124. doi: 10.1093/sleep/zsad124. DOI: https://doi.org/10.1093/sleep/zsad124

Rotteveel A H, Lambooij M S G, de Wit A. Benzodiazepinen uit het basispakket. Ned Tijdschr Geneeskd 2021. SOURCE???

Kalkman G A, Kramers C, van Dongen R T, van den Brink W, Schellekens A. Trends in use and misuse of opioids in the Netherlands: a retrospective, multi-source database study. Lancet Public Health 2019; 4(10): e498-e505. doi: 10.1016/S2468-2667(19)30128-8. DOI: https://doi.org/10.1016/S2468-2667(19)30128-8

Bedene A, Lijfering W M, Niesters M, van Velzen M, Rosendaal F R, Bouvy M L, et al. Opioid prescription patterns and risk factors associated with opioid use in the Netherlands. JAMA Netw Open 2019; 2(8): e1910223. doi: 10.1001/jamanetworkopen.2019.10223. DOI: https://doi.org/10.1001/jamanetworkopen.2019.10223

Landelijke Registratie Orthopedische Interventies (LROI). LROI annual report 2017. Available from: https://www.lroi.nl/jaarrapportage/previous-reports/

Landelijke Registratie Orthopedische Interventies (LROI). LROI annual report 2019. Available from: https://www.lroi.nl/jaarrapportage/previous-reports/

Landelijke Registratie Orthopedische Interventies (LROI). LROI annual report 2022. Available from: https://www.lroi.nl/jaarrapportage/previous-reports/

Houweling P L, Molag M L, van Boekel R L, Verbrugge S J, van Haelst I M, Hollmann M W. [“Postoperative pain treatment” practice guideline revised]. Ned Tijdschr Geneeskd 2013; 157(49): A7005. Herziene richtlijn “Postoperatieve pijn”.

Kehlet H. Multimodal approach to control postoperative pathophysiology and rehabilitation. Br J Anaesth 1997; 78(5): 606-17. doi: 10.1093/bja/78.5.606. DOI: https://doi.org/10.1093/bja/78.5.606

Dutch National Patient Safety Programme: Early recognition and treatment of pain [in Dutch].

Koch F C, Olivier J, Brett J, Buckley N A, Gisev N, Pearson S, et al. The impact of tightened prescribing restrictions for PBS-subsidised opioid medicines and the introduction of half-pack sizes, Australia, 2020–21: an interrupted time series analysis. Med J Aust 2024; 220(6): 315-22. doi: 10.5694/mja2.52257. DOI: https://doi.org/10.5694/mja2.52257

Cebron Lipovec N. Opioid analgesics prescribing trends 2010–2019 in Slovenia: national database study. Hum Psychopharmacol 2024: e2891. doi: 10.1002/hup.2891. DOI: https://doi.org/10.1002/hup.2891

Bahoravitch T, Roberts M, Zhao A, Stake S, Ernst B, Thakkar S C. Trends From 2010 to 2019 in opioid and nonopioid pain management after total knee arthroplasty. J Am Acad Orthop Surg Glob Res Rev 2024; 8(6): e23.00062. doi: 10.5435/JAAOSGlobal-D-23-00062. DOI: https://doi.org/10.5435/JAAOSGlobal-D-23-00062

Kristiansen E B, Pedersen A B. Variation in risk of opioid therapy and association with mortality following hip or knee arthroplasty: an analysis based on 14 different definitions. Acta Orthop 2025; 96: 664-70. doi: 10.2340/17453674.2025.44572. DOI: https://doi.org/10.2340/17453674.2025.44572

Brat G A, Agniel D, Beam A, Yorkgitis B, Bicket M, Homer M, et al. Postsurgical prescriptions for opioid naive patients and association with overdose and misuse: retrospective cohort study. BMJ 2018; 360: j5790. doi: 10.1136/bmj.j5790. DOI: https://doi.org/10.1136/bmj.j5790

Brummett C M, Evans-Shields J, England C, Kong A M, Lew C R, Henriques C, et al. Increased health care costs associated with new persistent opioid use after major surgery in opioid-naive patients. J Manag Care Spec Pharm 2021; 27(6): 760-71. doi: 10.18553/jmcp.2021.20507. DOI: https://doi.org/10.18553/jmcp.2021.20507

Hansen J L, Heilig M, Kalso E, Stubhaug A, Knutsson D, Sandin P, et al. Problematic opioid use among osteoarthritis patients with chronic post-operative pain after joint replacement: analyses from the BISCUITS study. Scand J Pain 2023; 23(2): 353-63. doi: 10.1515/sjpain-2022-0137. DOI: https://doi.org/10.1515/sjpain-2022-0137

Zhang K, Strahan A E, Guy G P, Larochelle M R. Trends in concurrent opioid and benzodiazepine prescriptions in the United States, 2016 to 2019. Ann Intern Med 2022; 175(7): 1051-3. doi: 10.7326/M21-4656. DOI: https://doi.org/10.7326/M21-4656

Shah R, Raji M A, Westra J, Kuo Y F. Association of co-prescribing of opioid and benzodiazepine substitutes with incident falls and fractures among older adults: a cohort study. BMJ Open 2021; 11(12): e052057. doi: 10.1136/bmjopen-2021-052057. DOI: https://doi.org/10.1136/bmjopen-2021-052057

Musich S, Wang S S, Slindee L B, Ruiz J, Yeh C S. Concurrent use of opioids with other central nervous system-active medications among older adults. Popul Health Manag 2020; 23(4): 286-96. doi: 10.1089/pop.2019.0128. DOI: https://doi.org/10.1089/pop.2019.0128

Hung A, Bush C, Greiner M, Campbell H, Hammill B, Maciejewski M L, et al. Risk factors and outcomes of opioid users with and without concurrent benzodiazepine use in the North Carolina Medicaid population. J Manag Care Spec Pharm 2020; 26(2): 169-75. doi: 10.18553/jmcp.2020.26.2.169. DOI: https://doi.org/10.18553/jmcp.2020.26.2.169

Zint K, Haefeli W E, Glynn R J, Mogun H, Avorn J, Sturmer T. Impact of drug interactions, dosage, and duration of therapy on the risk of hip fracture associated with benzodiazepine use in older adults. Pharmacoepidemiol Drug Saf 2010; 19(12): 1248-55. doi: 10.1002/pds.2031. DOI: https://doi.org/10.1002/pds.2031

Wagner A K, Zhang F, Soumerai S B, Walker A M, Gurwitz J H, Glynn R J, et al. Benzodiazepine use and hip fractures in the elderly: who is at greatest risk? Arch Intern Med 2004; 164(14): 1567-72. doi: 10.1001/archinte.164.14.1567. DOI: https://doi.org/10.1001/archinte.164.14.1567

Duarte N, Martins J P, Garcia-Pedraza J A, Santos M. Ten-year analgesic utilization patterns and economic implications in Portugal. Br J Clin Pharmacol 2024; doi: 10.1111/bcp.16333. DOI: https://doi.org/10.1111/bcp.16333

Arndt K B, Schroder H M, Troelsen A, Lindberg-Larsen M. Opioid and analgesic use before and after revision knee arthroplasty for the indications “pain without loosening” versus “aseptic loosening”: a Danish nationwide study. J Arthroplasty 2022; 37(8): 1618-25 e3. doi: 10.1016/j.arth.2022.03.077. DOI: https://doi.org/10.1016/j.arth.2022.03.077

Published

2025-10-10

How to Cite

Yepes-Calderón, M., Nelissen, R. G. H. H., Bouvy, M. L., Rosendaal, F. R., van Steenbergen, L. N., Dahan, A., & Gademan, M. G. J. (2025). 10-year trends in benzodiazepine, opioid, and concurrent use in hip and knee arthroplasty: a nationwide cohort study from the Netherlands. Acta Orthopaedica, 96, 771–779. https://doi.org/10.2340/17453674.2025.44755

Issue

Section

Publications

Categories